The cytotoxicity of phloridzin stems from its ability to inhibit GLUT1 and GLUT2, restricting glucose transport in cancer cells and thereby impairing their energy metabolism and biosynthetic capacity, ultimately suppressing tumor growth (Kilit and Aydemir 2022; Wu et al. 2009). Here, SLC2A1 is linked to neoplasm.